|
Conveners of INSA Local Chapter
Council at its meeting on 26th
December appointed conveners for its following local
chapters:
|
Local Chapter |
Convener |
|
Allahabad
(All
Fellows in Allahabad)
Ahmedabad
(All
Fellows
in
Gujarat and Rajasthan) |
Amitava Raychaudhuri |
Bangalore
(All
Fellows in Karnataka)
Bhubaneswar
(All
Fellows
in
Orissa and Bihar) |
AK
Singhvi |
Bhubaneswar
(All
Fellows in Orissa and Bihar) |
AV Khare
|
|
Chandigarh
(All
Fellows in Haryana, Chandigarh,HP,J&k and Punjab (except
Ludhiana, Amritsar & Patiala) |
RC
Mahajan |
Chennai
(All
Fellows in
Tirupati,
Tamil Nadu) (except Madurai, Karaikudi and Trichy) |
G
Baskaran |
Delhi
(All
Fellows in Agra, Aligarh, Delhi, Gwalior, Meerut, Sagar
andBhopal, Gurgaon,Ghaziabad, Noida) |
Rajendra Prasad |
Hyderabad
(All
Fellows in Andhra Pradesh) |
JS
Yadav |
Kharagpur
(All
Fellows in Durgapur & Kharagpur) |
PP
Chakrabarti |
Kolkata
(All
Fellows in
Burdwan,
Kolkata, Jadavpur, Kalyani and Shillong) |
CK
Dasgupta |
Lucknow
(All
Fellows in
Kanpur,
Lucknow, Nainital,Pantnagar and Ranikhet) |
Rakesh Tuli |
Ludhiana
(All
Fellows in Ludhiana, Amritsar & Patiala) |
PR
Gajri |
Madurai
(All
Fellows in Madurai Pondicherry, Karaikudi and Trichy) |
G
Marimuthu |
Mumbai
(All
Fellows in Mumbai and Indore) |
SK
Apte |
Pune
(All
Fellows in Pune, Ahmedanagar, Aurangabad, Goa) |
Sourav Pal |
Roorkee
(All
Fellows in Roorkee, Dehradun, Garwal, Sringar (UP) |
AK
Jain |
Thiruvananthapuram
(All
Fellows in Kerala) |
TK
Chandrashekar |
Varanasi
(All
Fellows in Azamgarh, Gorakhpur & Varanasi) |
Rajiva Raman |
|
|
Local Chapter Activities
Shambu Nath De Memorial Lecture 2002
Professor RC Mahajan, FNA, delivered Shambu Nath De Memorial Lecture
on “Perspectives of
Amoebiasis – Diagnosis & Drug Resistance”
at

The artistes performing the dance recital
University of Guwahati, Guwahati
on 19 th
October 2005.
Professor Mahajan described in
his lecture how parasitic diseases continue to be a major public
health problem all over the world with associated high degree of
mortality, morbidity & man day loss. WHO statistics put parasites as
leading cause of death after HIV/AIDS and Tuberculosis. One out of
10 living persons suffer from one or more of seven major tropical
diseases of which five are parasitic in nature.Amoebiasis caused by
cytolytic enteric protozoan,
E. histolytica, occurs world
wide affecting nearly 500 million persons and is regarded as the
second most important cause of death due to protozoal infection next
to malaria morphologically similar
E.dispar
is nonpathogenic and does not
require antiamoebic drugs to treat. By biochemical and molecular
biological techniques, these two species can be differentiated.For
intestinal infections, conventional microscopic stool examination
continues to be best diagnostic approach. However, for
extra-intestinal infections, indirect methods like amoebic
antigen/antibody detection and molecular techniques have proved to
be highly sensitive and specific both as diagnostic and prognostic
tools. Judicious use of currently available very few antiamoebic
drugs is important to avoid increased MIC value against the parasite
& treatment failure because of drug resistance, which could
seriously pose problem in controlling this disease. Development of
new drugs and vaccine appear to be distant dream. Understanding the
mechanism of drug resistance development is thus important. We have
reported significantly higher IC50 value of all the four antiamoebic
drugs, metronidazole, tinidazole, choroquine and emetine to the
clinical isolates compared to the reference strain HM1:1MSS.
E. histolytica has several
features common with MDR phenotype described in mammalian tumor
cells. These are cross resistance to unrelated drugs,increased
efflux and decreased accumulation of radiolabelled drugs, reversal
of resistance by calcium channel blockers and overexpression of 4.5
kb long mRNA homologous to the mammalian P glycoprotein. Six Pgps
like genes have been cloned and sequenced. Entamoeba Pgps are more
related to human and mouse Pgps. Differential gene expression has
been detected in emetine resistant mutants. We have shown
overexpression of MDR gene in resistant mutant with no mRNA
expression in clinical E.
histolytical & E. dispar
isolates and known sensistieve strain suggesting thereby that
more than one mechanism may be operating in
E. histolytica for drug
resistance development. Further studies to evaluate the MDR
phenotype in clinical isolates are therefore desired.
|
|